연구성과로 돌아가기

2023 연구자 정보 (1087 / 1135)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 교신저자 여부 Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Kim, Heeho
(Kim, H)
제1저자 교신저자 Kyungpook Natl Univ, Sch Econ & Trade, Daehak Ro 80, Daegu, South Korea AAO-8809-2021
Kim, Heeho
0000-0002-7675-6969
Kim, Heeho
[JCR상위 81.4] Data Restriction Policies and Institutional Quality ESCI 81.4 ECONOMICS kimhh@knu.ac.kr;
Zhang, Hongxia
(Zhang, HX)
Shandong Normal Univ, Sch Econ, 88 East Wenhua Rd, Jinan, Shandong, Peoples R China

[JCR상위 81.4] Data Restriction Policies and Institutional Quality ESCI 81.4 ECONOMICS kimhh@knu.ac.kr;
Ahn, Joong Bae
(Ahn, JB)
Yonsei Univ, Severance Hosp, Dept Internal Med, Coll Med, Seoul, South Korea
0000-0001-6787-1503
Ahn, Joong Bae
[JCR상위 81.5] Prospective, open-label, and observational study of cetuximab for metastatic colorectal carcinoma: The OPTIM1SE study SCIE 81.5 ONCOLOGY pys27hmo@skku.edu;
Anh, Le Tuan
(Anh, L)
Cho Ray Hosp, Dept Med & Radiat Oncol, Ho Chi Minh City, Vietnam AAC-9851-2022
Le, Anh Tuan

[JCR상위 81.5] Prospective, open-label, and observational study of cetuximab for metastatic colorectal carcinoma: The OPTIM1SE study SCIE 81.5 ONCOLOGY pys27hmo@skku.edu;
Bo-Wen, Lin
(Bo-Wen, L)
Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Surg, Tainan, Taiwan

[JCR상위 81.5] Prospective, open-label, and observational study of cetuximab for metastatic colorectal carcinoma: The OPTIM1SE study SCIE 81.5 ONCOLOGY pys27hmo@skku.edu;
Burge, Matthew
(Burge, M)
Royal Brisbane & Womens Hosp, Dept Med Oncol, Brisbane, Qld, Australia

[JCR상위 81.5] Prospective, open-label, and observational study of cetuximab for metastatic colorectal carcinoma: The OPTIM1SE study SCIE 81.5 ONCOLOGY pys27hmo@skku.edu;
Chen, Hong-Hwa
(Chen, HH)
Chang Gung Mem Hosp, Dept Colorectal Surg, Kaohsiung, Taiwan

[JCR상위 81.5] Prospective, open-label, and observational study of cetuximab for metastatic colorectal carcinoma: The OPTIM1SE study SCIE 81.5 ONCOLOGY pys27hmo@skku.edu;
Chua, Clarinda
(Chua, C)
Natl Canc Ctr, Div Med Oncol, Singapore, Singapore

[JCR상위 81.5] Prospective, open-label, and observational study of cetuximab for metastatic colorectal carcinoma: The OPTIM1SE study SCIE 81.5 ONCOLOGY pys27hmo@skku.edu;
Huang, Jason
(Huang, J)
Merck Pte Ltd, Singapore, Singapore
Merck KGaA, Darmstadt, Germany


[JCR상위 81.5] Prospective, open-label, and observational study of cetuximab for metastatic colorectal carcinoma: The OPTIM1SE study SCIE 81.5 ONCOLOGY pys27hmo@skku.edu;
Jeon, Hosang
(Jeon, H)
제1저자 Pusan Natl Univ, Yangsan Hosp, Dept Radiat Oncol, Yangsan, South Korea
Pusan Natl Univ, Yangsan Hosp, Res Inst Convergence Biomed Sci & Technol, Yangsan, South Korea


[JCR상위 81.5] Influence of respiratory movement during post mastectomy radiotherapy on targets and heart for breast cancer SCIE 81.5 ONCOLOGY hi_juji@daum.net;
Joo, Ji Hyeon
(Joo, JH)
교신저자 Pusan Natl Univ, Dept Radiat Oncol, Sch Med, Yangsan, South Korea
Pusan Natl Univ, Dept Radiat Oncol, Yangsan Hosp, Yangsan, South Korea
Pusan Natl Univ, Yangsan Hosp, Dept Radiat Oncol, Sch Med, Yangsan, Gyeongnam, South Korea

0000-0001-9275-3197
Joo, Ji Hyeon
[JCR상위 81.5] Influence of respiratory movement during post mastectomy radiotherapy on targets and heart for breast cancer
[JCR상위 1.5] Korean Real-World Data on Patients With Unresectable Stage III NSCLC Treated With Durvalumab After Chemoradiotherapy: PACIFIC-KR
SCIE 1.5 ONCOLOGY
ONCOLOGY;RESPIRATORY SYSTEM
hi_juji@daum.net;
droij@jnu.ac.kr;
Ki, Yongkan
(Ki, Y)
Pusan Natl Univ, Dept Radiat Oncol, Sch Med, Yangsan, South Korea
Pusan Natl Univ, Dept Radiat Oncol, Yangsan Hosp, Yangsan, South Korea


[JCR상위 81.5] Influence of respiratory movement during post mastectomy radiotherapy on targets and heart for breast cancer SCIE 81.5 ONCOLOGY hi_juji@daum.net;
Kim, Dong Woon
(Kim, DW)
Pusan Natl Univ, Dept Radiat Oncol, Yangsan Hosp, Yangsan, South Korea

[JCR상위 81.5] Influence of respiratory movement during post mastectomy radiotherapy on targets and heart for breast cancer SCIE 81.5 ONCOLOGY hi_juji@daum.net;
Kim, Wontaek
(Kim, W)
Pusan Natl Univ, Dept Radiat Oncol, Sch Med, Yangsan, South Korea
Pusan Natl Univ Hosp, Dept Radiat Oncol, Busan, South Korea


[JCR상위 81.5] Influence of respiratory movement during post mastectomy radiotherapy on targets and heart for breast cancer SCIE 81.5 ONCOLOGY hi_juji@daum.net;
Lee, Myung-Ah
(Lee, MA)
Catholic Univ Korea, Seoul St Marys Hosp, Seoul, South Korea
Catholic Univ Korea, Coll Med, Canc Res Inst, Div Med Oncol,Dept Internal Med,Seoul St Marys Ho, Seoul, South Korea


[JCR상위 81.5] Prospective, open-label, and observational study of cetuximab for metastatic colorectal carcinoma: The OPTIM1SE study
[JCR상위 50.5] Safety and effectiveness of aflibercept in combination with FOLFIRI in Korean patients with metastatic colorectal cancer who received oxaliplatin-containing regimen
SCIE 50.5 ONCOLOGY pys27hmo@skku.edu;
jkk21c@knu.ac.kr;
페이지 이동: